132 related articles for article (PubMed ID: 1765898)
1. Spontaneous formation of drug-containing acrylic nanoparticles.
Bodmeier R; Chen H; Tyle P; Jarosz P
J Microencapsul; 1991; 8(2):161-70. PubMed ID: 1765898
[TBL] [Abstract][Full Text] [Related]
2. Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation.
Babak VG; Baros F; Boulanouar O; Boury F; Fromm M; Kildeeva NR; Ubrich N; Maincent P
Colloids Surf B Biointerfaces; 2007 Oct; 59(2):194-207. PubMed ID: 17600692
[TBL] [Abstract][Full Text] [Related]
3. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
6. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
Abbaspour MR; Sadeghi F; Garekani HA
Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
[TBL] [Abstract][Full Text] [Related]
9. Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.
Bodmeier R; Paeratakul O
Pharm Res; 1994 Jun; 11(6):882-8. PubMed ID: 7937530
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation.
Ueda M; Nakamura Y; Makita H; Kawashima Y
J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491
[TBL] [Abstract][Full Text] [Related]
12. Microencapsulation of antimicrobial ceftiofur drugs.
Bodmeier R; Chen H; Davidson RG; Hardee GE
Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
[TBL] [Abstract][Full Text] [Related]
13. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation.
Bouchemal K; Briançon S; Perrier E; Fessi H
Int J Pharm; 2004 Aug; 280(1-2):241-51. PubMed ID: 15265563
[TBL] [Abstract][Full Text] [Related]
14. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
[TBL] [Abstract][Full Text] [Related]
15. Oil-in-oil microencapsulation technique with an external perfluorohexane phase.
Mana Z; Pellequer Y; Lamprecht A
Int J Pharm; 2007 Jun; 338(1-2):231-7. PubMed ID: 17368983
[TBL] [Abstract][Full Text] [Related]
16. Morphology and surface properties of blends of Eudragit RS with different poly(ethylene glycol)s.
Lovrecich M; Rubessa F
Pharm Dev Technol; 1998 Feb; 3(1):123-9. PubMed ID: 9532607
[TBL] [Abstract][Full Text] [Related]
17. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):404-9. PubMed ID: 20034769
[TBL] [Abstract][Full Text] [Related]
18. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
19. Electrohydrodynamic atomization for biodegradable polymeric particle production.
Xie J; Lim LK; Phua Y; Hua J; Wang CH
J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of polymeric nanoparticles into solid dosage forms.
Schmidt C; Bodmeier R
J Control Release; 1999 Feb; 57(2):115-25. PubMed ID: 9971890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
